ST
HZNP

Spot Trading’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Spot Trading’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$257K Buy
20,300
+16,600
+449% +$211K ﹤0.01% 2073
2017
Q2 		$44K Buy
+3,700
New +$46K ﹤0.01% 2852
2017
Q1 		– Sell
-10,000
Closed -$162K – 3504
2016
Q4 		$162K Buy
10,000
+1,200
+14% +$21.8K ﹤0.01% 2024
2016
Q3 		$160K Sell
8,800
-2,900
-25% -$56.7K ﹤0.01% 2217
2016
Q2 		$193K Buy
+11,700
New +$189K ﹤0.01% 2249
2016
Q1 		– Sell
-40,000
Closed -$867K – 4278
2015
Q4 		$867K Buy
40,000
+13,600
+52% +$265K 0.01% 1557
2015
Q3 		$523K Buy
+26,400
New +$834K 0.01% 2022
2015
Q2 		– Sell
-200
Closed -$5K – 4427
2015
Q1 		$5K Buy
+200
New +$3.67K ﹤0.01% 3667

Other funds holding HZNP

SCM
Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BGIM
Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Spot Trading's HZNP Position: Q3 2017 in Review

Spot Trading opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2017: 17,005 shares worth $216K. The stake represents ﹤0.01% of the portfolio and ranks #2186 among its holdings. This is a return to the name: Spot Trading previously reported a position in HZNP as recently as Q4 2016.

Spot Trading first reported a position in HZNP in Q4 2015 and has held it in 4 quarters since. The position peaked at $748K in Q4 2015. 181 funds tracked by Wall St. Rank hold HZNP as of Q3 2017.

  • Spot Trading held 17,005 shares of Horizon Therapeutics Public Limited Company Ordinary Shares worth $216K as of Q3 2017.
  • Horizon Therapeutics Public Limited Company Ordinary Shares was a new Spot Trading position in Q3 2017.
  • Horizon Therapeutics Public Limited Company Ordinary Shares made up ﹤0.01% of Spot Trading's portfolio in Q3 2017, its #2186 holding.
  • Spot Trading first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2015 and has held it in 4 quarters since.
  • Spot Trading's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $748K in Q4 2015.
  • 181 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.